Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Political Oversight Of Agency Guidances, Rules Slated For House Hearing

Executive Summary

Two House subcommittees are planning a joint hearing on amended 1Executive Order 12866, which institutionalizes the review of federal agency regulations and guidance documents by presidential appointees rather than career agency staff

You may also be interested in...



Congress Urged To Address Expanded OMB Role In Regulations, Guidances

The government watchdog group OMB Watch is urging Congress to take action against an executive order that increases the administration's influence over regulations and guidance documents issued by FDA and other agencies

Congress Urged To Address Expanded OMB Role In Regulations, Guidances

The government watchdog group OMB Watch is urging Congress to take action against an executive order that increases the administration's influence over regulations and guidance documents issued by FDA and other agencies

HHS Deputy Secretary Azar to depart

Alex Azar leaves his HHS post Feb. 3 to return to the private sector. Before serving as deputy secretary, Azar was HHS general counsel from 2001 to 2005. He had been involved in implementing the Medicare prescription drug benefit and was on the HHS importation task force...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS048026

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel